DIA 48th Annual Meeting
Click here to go to the previous page
Risks to and Securing of Global Drug Supply Chains
Track : Track 17: Global Regulatory
Program Code: 324
Date: Wednesday, June 27, 2012
Time: 8:00 AM to 9:30 AM  EST
CHAIR :
 Connie Jung, FDA, United States
PRESENTER (S):
S. Leigh Verbois, FDA, United States
 Gregg Goneconto, FDA, United States
 Christa Wirthumer-Hoche, Austrian Medicinal and Medical Device Agency (AGES ), Austria
Description
This town hall is intended to be an open forum discussion on the risks to human drugs created by complex global supply chains, greater foreign sourcing of products and the increase in volume of imports along with current efforts by regulators and industry to ensure product safety and quality.

Learning Objectives:
Describe the impact of globalization and the various threats and vulnerabilities to the human drug supply chain
Describe challenges and regulatory efforts underway for drug security and protection of public health
Discuss collaborative private sector efforts to assure the safe transit of drugs.


Handout Online
View